Highlights from PNC 2024 - Children's National

Children's National Hospital served as a strategic partner for Sidra Medicine's 4th annual Pediatric Neuroscience Conference (PNC 2024) which took place in Doha, Qatar. This collaboration emphasizes a mutual commitment to advancing pediatric neurological care and research.

The conference offered a robust platform for presenting groundbreaking research and clinical advancements across diverse subfields such as pediatric neurology, neurosurgery, neuro-critical care, neurogenetics, neuroimmunology and neuroradiology. Esteemed medical professionals and researchers from around the world convened to share insights and innovations that are shaping the future of pediatric neurological health.

Various speakers from Children's National led in-depth discussions on diagnostic and therapeutic innovations aimed at enhancing outcomes for children with chronic neurological and neurosurgical conditions. PNC 2024 provided an excellent platform for healthcare professionals, researchers and academics to update their knowledge and engage with leading specialists in the field.

Presenters and topics from Children's National included:

• Dana Harrar, M.D., Ph.D. : Pediatric Status Epilepticus - Monitoring and Management, Acute Stroke: Diagnosis and Critical Care Management
• Daniel Donoho, M.D.: Implementing AI in the Operating Room: State of the Art and Future Directions
• Diana Bharucha-Goebel, M.D.: Hypotonia & Arthrogryposis
• Robert Keating, M.D.< /a>: Neonatal Neurosurgery Update: Where are we today?
• Sarah Schlatterer, M.D., Ph.D. : Neurocardiac Critical Care
• Sarah Wright, D.O .: Personalized Treatment in DMD
• Tayyba Anwar, M. D.: Neonatal Encephalopathies other than HIE, Personalized Treatments for Genetic Epilepsy
• Youssef Kousa, M.S., D.O., Ph .D.: Prenatal and Neonatal CNS Infections, Difficult Goals of Care and Outcome Discussions in the Neonatal ICU

The collaborative efforts with Sidra Medicine highlight a shared vision of pushing the boundaries of pediatric neurological research and treatment, ultimately aiming to improve outcomes for young patients worldwide.